Physician

Aaron Ross Chidakel, M.D.

According to 2025 Medicare claims, Aaron Chidakel, M.D. (NPI: 1245341619) practices endocrinology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from New York, NY. This provider's primary affiliated billing organization is NEW YORK UNIVERSITY (NPI: 1285826438; TIN: 472665045) and primary practice location at 10022-3205.

Chidakel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 396 traditional Medicare patients, billed 1,767 HCPCS/CPT codes, and received $80,965 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,894 prescription claims across 398 beneficiaries totaling $1,325,487 in drug costs, led by Ozempic (Semaglutide). DME data shows 148 claims. Open Payments data shows 6 records totaling $409. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $393,580 to $1,325,487. For DME billing, reported payments moved sharply higher in recent years, from $8,877 to $32,517.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	261	776	$53,502
2016	135	430	$34,985
2017	173	1,447	$41,000
2018	241	6,748	$49,947
2019	284	6,945	$52,220
2020	298	6,654	$48,894
2021	159	3,386	$17,013
2022	270	2,039	$49,857
2023	326	6,378	$66,638
2024	396	1,767	$80,965

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	197	1,121	$393,580
2016	119	871	$304,765
2017	162	1,035	$397,511
2018	230	1,574	$635,914
2019	257	1,748	$763,146
2020	288	2,235	$878,691
2021	245	1,406	$589,880
2022	249	1,246	$547,484
2023	353	2,382	$1,180,479
2024	398	2,894	$1,325,487

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	133	362	$16,028
2016	61	136	$8,100
2017	19	57	$1,121
2018	43	97	$1,592
2019	51	129	$5,527
2020	55	162	$10,943
2021	41	105	$7,624
2022	18	81	$7,947
2023	47	139	$15,539
2024	48	148	$30,203

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	14	15	$139
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	127	127	$133
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	232	423	$99
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	45	49	$67
36415	Insertion of needle into vein for collection of blood sample	208	305	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	186	10,382	$327,294
Mounjaro	Tirzepatide	164	5,890	$206,469
Jardiance	Empagliflozin	89	6,660	$125,843
Trulicity	Dulaglutide	71	2,926	$95,729
Farxiga	Dapagliflozin Propanediol	71	4,710	$84,442

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	17	78	$29,331
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	18	43	$824
A4259	Lancets, per box of 100	N	13	27	$48

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$409	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Ross Chidakel, M.D.?

Tedicare shows public-source Medicare data for Aaron Ross Chidakel, M.D. (NPI 1245341619), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Ross Chidakel, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Aaron Ross Chidakel, M.D.?

Aaron Ross Chidakel, M.D. is linked to NEW YORK UNIVERSITY (billing NPI 1285826438) in the available physician profile data.

Does Aaron Ross Chidakel, M.D. have Open Payments data?

Aaron Ross Chidakel, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.